- Filed
- Feb 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 8.62M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 8.58M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 8.52M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 8.39M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $134K |
| Capex | Q3 2025 · Sep 30, 2024 | $129K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $2.49M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $4.24M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $19.73M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $61.37M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $261.69M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $284.97M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.07B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.05B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.34B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.33B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.86 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$3.27 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.03 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.86 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$3.27 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Net Income | Q3 2025 · Sep 30, 2025 | −$23.88M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$25.82M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $516K |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $618K |
| Revenue | Q3 2025 · Sep 30, 2025 | $47K |
| Revenue | Q3 2025 · Sep 30, 2025 | $131K |
| Revenue | Q3 2025 · Sep 30, 2024 | $36K |
| Revenue | Q3 2025 · Sep 30, 2024 | $114K |